Page 700 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 700

686     SECTION VII  Endocrine Drugs


                 Taylor BE, Buchman TG: Is there a role for growth hormone therapy in refractory   Westhoff G, Cotter AM, Tolosa JE: Prophylactic oxytocin for the third stage of
                    critical illness? Curr Opin Crit Care Med 2008;14:438.  labour to prevent postpartum haemorrhage. Cochrane Database Syst Rev
                 Tena-Sempere M: Deciphering puberty: Novel partners, novel mechanisms. Eur J   2013;(10):CD001808.
                    Endocrinol 2012;167:733.                         Wit JM et al: Idiopathic short stature: Definition, epidemiology, and diagnostic
                 Wales PW et al: Human growth hormone and glutamine for patients with short   evaluation. Growth Horm IGF Res 2008;18:89.
                    bowel syndrome. Cochrane Database Syst Rev 2010;(16):CD006321.  Youssef MA et al: Gonadotropin-releasing hormone agonist versus HCG for
                 Webster J et al: A comparison of cabergoline and bromocriptine in the treatment of   oocyte triggering in antagonist assisted reproductive technology cycles.
                    hyperprolactinemic amenorrhea. N Engl J Med 1994;331:904.  Cochrane Database Syst Rev 2011;(1):CD008046.




                   C ASE  STUD Y  ANSWER

                   While  growth  hormone  (GH)  may  have  some  direct   at risk for multiple hypothalamic/pituitary deficiencies.
                   growth-promoting effects, it is thought to mediate skeletal   He may already have or may subsequently develop ACTH/
                   growth principally through production of insulin-like   cortisol and TSH/thyroid hormone deficiencies and thus
                   growth factor-I (IGF-I) at the epiphyseal plate, which acts   may require supplementation with hydrocortisone and
                   mainly in an autocrine/paracrine manner. IGF-I may also   levothyroxine, in addition to supplementation with GH
                   promote statural growth through endocrine mechanisms.   and testosterone. He should also be evaluated for the pres-
                   The findings of small testes and a microphallus in this   ence of central diabetes insipidus and, if present, treated
                   patient suggest a diagnosis of hypogonadism, likely as a   with desmopressin, a V  vasopressin receptor–selective
                                                                                          2
                   consequence of gonadotropin deficiency. This patient is   analog.
   695   696   697   698   699   700   701   702   703   704   705